Brad Spellberg
Impact in
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
Papers in
-
- Antifungal resistance and susceptibility 59
- Antimicrobial Resistance in Staphylococcus 19
- Epidemiology 69
- Fungal Infections and Studies 38
- Pneumocystis jirovecii pneumonia detection and treatment 12
- Co-authors
- John E. Edwards (44 shared papers)Ashraf S. Ibrahim (51 shared papers)David N. Gilbert (12 shared papers)John S. Bradley (5 shared papers)Helen W. Boucher (5 shared papers)George H. Talbot (3 shared papers)John Bartlett (2 shared papers)John G. Bartlett (8 shared papers)
- Journals
- Clinical Infectious Diseases (30 papers)Antimicrobial Agents and Chemotherapy (20 papers)The Journal of Infectious Diseases (14 papers)PLoS ONE (10 papers)Open Forum Infectious Diseases (10 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Brad Spellberg
211 papers receiving 21.3k citations
Brad Spellberg's Hit Papers
Peers
Comparison fields: 5 of 186
- Molecular Medicine 4.9k
- Applied Microbiology and Biotechnology 1.8k
- Infectious Diseases 8.9k
- Endocrinology 1.4k
- Microbiology 1.6k
Countries citing papers authored by Brad Spellberg
This map shows the geographic impact of Brad Spellberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Spellberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Spellberg more than expected).
Fields of papers citing papers by Brad Spellberg
This network shows the impact of papers produced by Brad Spellberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Spellberg. The network helps show where Brad Spellberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Brad Spellberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 218 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America Hit paper breakdown → | 2008 | 3938 |
| 2 | The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America Hit paper breakdown → | 2007 | 1264 |
| 3 | Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management Hit paper breakdown → | 2005 | 1009 |
| 4 | Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges Hit paper breakdown → | 2017 | 862 |
| 5 | Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los Angeles Hit paper breakdown → | 2005 | 765 |
| 6 | Type 1/Type 2 Immunity in Infectious Diseases Hit paper breakdown → | 2001 | 682 |
| 7 | Trends in Antimicrobial Drug Development: Implications for the Future Hit paper breakdown → | 2004 | 634 |
| 8 | Nosocomial fungal infections: epidemiology, diagnosis, and treatment Hit paper breakdown → | 2007 | 571 |
| 9 | Pathogenesis of Mucormycosis Hit paper breakdown → | 2012 | 522 |
| 10 | 2013 | 470 | |
| 11 | 2009 | 385 | |
| 12 | 2009 | 366 | |
| 13 | 2008 | 362 | |
| 14 | 2013 | 337 | |
| 15 | 2011 | 326 | |
| 16 | 1998 | 305 | |
| 17 | 2007 | 242 | |
| 18 | 2010 | 238 | |
| 19 | 2011 | 226 | |
| 20 | 2007 | 210 |
About Brad Spellberg
Brad Spellberg is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Applied Microbiology and Biotechnology and Immunology, having authored 218 papers that have together received 21.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (59 papers), Antibiotic Resistance in Bacteria (48 papers), Fungal Infections and Studies (38 papers), Antibiotic Use and Resistance (26 papers), Antimicrobial Resistance in Staphylococcus (19 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). The work is most often cited by research in Molecular Medicine (4.9k citations), Applied Microbiology and Biotechnology (1.8k citations), Infectious Diseases (8.9k citations), Endocrinology (1.4k citations) and Microbiology (1.6k citations). Brad Spellberg has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John E. Edwards, Ashraf S. Ibrahim, David N. Gilbert, John S. Bradley, Helen W. Boucher, George H. Talbot, John Bartlett, John G. Bartlett, Michael Scheld and Louis B. Rice. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, PLoS ONE and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.